Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group.
Yenamandra AK, Smith RB, Senaratne TN, Kang SL, Fink JM, Corboy G, Hodge CA, Lu X, Mathew S, Crocker S, Fang M. Yenamandra AK, et al. Among authors: fang m. Cancer Genet. 2022 Nov;268-269:1-21. doi: 10.1016/j.cancergen.2022.07.006. Epub 2022 Aug 4. Cancer Genet. 2022. PMID: 35970109 Review.
Jumping translocations in myelodysplastic syndromes.
Yeung CCS, Deeg HJ, Pritchard C, Wu D, Fang M. Yeung CCS, et al. Among authors: fang m. Cancer Genet. 2016 Sep;209(9):395-402. doi: 10.1016/j.cancergen.2016.08.002. Epub 2016 Aug 8. Cancer Genet. 2016. PMID: 27751357 Free PMC article.
Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
Xu X, Bryke C, Sukhanova M, Huxley E, Dash DP, Dixon-Mciver A, Fang M, Griepp PT, Hodge JC, Iqbal A, Jeffries S, Kanagal-Shamanna R, Quintero-Rivera F, Shetty S, Slovak ML, Yenamandra A, Lennon PA, Raca G. Xu X, et al. Among authors: fang m. Cancer Genet. 2018 Dec;228-229:218-235. doi: 10.1016/j.cancergen.2018.07.005. Epub 2018 Oct 6. Cancer Genet. 2018. PMID: 30344013 Free article. Review.
Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms.
Kanagal-Shamanna R, Hodge JC, Tucker T, Shetty S, Yenamandra A, Dixon-McIver A, Bryke C, Huxley E, Lennon PA, Raca G, Xu X, Jeffries S, Quintero-Rivera F, Greipp PT, Slovak ML, Iqbal MA, Fang M. Kanagal-Shamanna R, et al. Among authors: fang m. Cancer Genet. 2018 Dec;228-229:197-217. doi: 10.1016/j.cancergen.2018.07.003. Epub 2018 Oct 10. Cancer Genet. 2018. PMID: 30377088 Free article. Review.
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
Pugh TJ, Fink JM, Lu X, Mathew S, Murata-Collins J, Willem P, Fang M; Cancer Genomics Consortium Plasma Cell Disorders Working Group. Pugh TJ, et al. Among authors: fang m. Cancer Genet. 2018 Dec;228-229:184-196. doi: 10.1016/j.cancergen.2018.07.002. Epub 2018 Oct 5. Cancer Genet. 2018. PMID: 30393007 Review.
4,310 results